Glycolipid compositions for transplanted tumor immunotherapy

Details Glycolipid compositions for transplanted tumor immunotherapy Glycolipid compositions for transplanted tumor immunotherapy

1978-08-04

1981-01-06

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Conjugate or complex of monoclonal or polyclonal antibody,...

Conjugated via claimed linking group, bond, chelating agent,...

424 92, 424180, 536116, 536119, C07H 1302, A61K 3171, A61K 3172

Patent

active

042436630

ABSTRACT:
A composition which is capable of specifically inducing an immunity when administered into the body of a host in association with a tumor antigen, or which is capable of non-specifically enhancing an immunizing function when administered into the body of a tumor-carrying host, comprising a glycolipid as active ingredient in association with a pharmaceutically acceptable carrier, wherein the saccharide moiety of the glycolipid is selected from the group consisting of fructose, glucose and sucrose.

REFERENCES:
patent: 3597417 (1971-08-01), Myhre
patent: 3631025 (1971-12-01), Martin
patent: 3634397 (1972-01-01), Thompson et al.
patent: 3839555 (1974-10-01), Billiau et al.

Affiliated with

Also associated with

Rating

Glycolipid compositions for transplanted tumor immunotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Glycolipid compositions for transplanted tumor immunotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycolipid compositions for transplanted tumor immunotherapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-285018